Symplmed introduces hypertension drug Prestalia in US

Prestalia, a first fixed-dose combination of perindopril arginine and amlodipine besylate, is now available by prescription for use in patients whose blood pressure is not adequately controlled on monotherapy.

The drug can also be used as initial therapy if a patient is likely to need multiple drugs to achieve their blood pressure goals.

Symplmed president and CEO Erik Emerson said: "This is the first time these two proven medications are available in a single pill, establishing a simple regimen for the more than three million patients who currently take an ACE inhibitor and a calcium channel blocker to control their blood pressure.

"By making Prestalia available through bpCareConnect, we are also giving physicians the opportunity to provide enhanced support for these patients beyond the exam room by lowering their prescription drug costs, actively monitoring their progress, and receiving treatment feedback in real time."

Perindopril arginine is an angiotensin converting enzyme (ACE) inhibitor and amlodipine is a dihydropyridine calcium channel blocker.